SONOCO PRODUCTS CO financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SONOCO PRODUCTS CO files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	4,893	5,188	5,531	5,501	5,349	5,720	5,859	5,441	5,305	7,519
Cost of revenue	3,837	4,078	4,350	4,316	4,191	4,529	4,634	4,239	4,166	5,944
Gross profit	946	959	1,041	1,058	1,046	1,062	1,225	1,203	1,139	1,574
Research and development	22.5	21	23.2	23.3	22	24.1	23.1	23.9	23	21.5
Selling, general and administrative	503	508	563	531	528	558	610	645	724	862
Operating income	505	412	438	467	358	487	563	589	327	1,018
Interest expense	54.2	57.2	63.1	66.8	75	64	102	137	173	233
Interest income	2.61	4.48	4.99	5.24	2.98	4.76	4.53	10	27.6	20.5
Other non-operating income						0	0	39.7	-104	-27.5
Pre-tax income	441	315	379	381	256	-161	460	489	63.5	765
Income tax	165	147	75	93.3	53	-67.4	95.7	120	5.51	184
Income from continuing operations							378	379	67.7	591
Net income to minority interests	1.45	2.1	1.18	0.88	-0.22	2.77	0.54	0.94
Net income	286	175	314	292	207	-85.5	466	475	164	1,003
EBITDA	710	630	674	706	619	732	872	930	701	1,537
EPS, basic	2.83	1.75	3.12	2.90	2.06	-0.86	4.76	4.83	1.66	10.12
EPS, diluted	2.81	1.74	3.10	2.88	2.05	-0.86	4.72	4.80	1.65	10.07
Shares, basic (weighted)	101	100	101	101	101	99.6	98	98.3	98.6	99.1
Shares, diluted (weighted)	102	101	101	101	101	99.6	98.7	98.9	99.3	99.6
Dividend per share	1.46	1.54	1.62	1.70	1.72	1.80	1.92	2.02	2.07	2.11

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	257	255	120	145	565	171	227	139	431	378
Receivables	625	725	737	698	659	756	863	686	908	843
Inventory									1,016	1,121
Other current assets	49.8	44.8	55.8	60.2	52.6	74	76.1	104	197	125
Total current assets	1,349	1,564	1,519	1,521	1,831	1,659	2,361	2,050	3,179	2,646
Property, plant and equipment	1,060	1,169	1,234	1,287	1,244	1,298	1,710	1,663	2,719	2,798
Lease right-of-use assets				298	296	268	297	233	308	307
Goodwill	1,092	1,242	1,309	1,429	1,389	1,325	1,675	1,298	2,526	2,512
Intangible assets	225	331	352	388	322	278	742	727	2,587	2,683
Other non-current assets	155	189	122	156	153	220	238	206	209	161
Total assets	3,923	4,558	4,583	5,126	5,277	5,073	7,053	7,192	12,508	11,162
Accounts payable	478	548	556	538	537	721	819	538	1,131	1,084
Accrued liabilities	205	217	237	289	430	291	296	265	464	778
Deferred revenue			18.5	17	16.7	19	22.4
Short-term debt	32	159	195	488	456	412	502	38.9	2,055	538
Total current liabilities	803	1,000	1,083	1,404	1,512	1,526	1,744	1,165	4,038	2,529
Long-term debt	1,021	1,288	1,190	1,193	1,244	1,199	2,720	2,998	4,985	3,789
Lease liabilities				254	262	234	251	193	259	263
Other non-current liabilities	38.1	110	99.8	78	91.1	35.9	38.1	49.4	60.8	215
Total liabilities	2,368	2,828	2,811	3,311	3,367	3,224	4,980	4,760	10,222	7,531
Total debt	1,053	1,447	1,385	1,193	1,244	1,199	2,720	2,998	4,985	3,789
Paid-in capital	321	330	305	311	314	120	141	159	183	192
Retained earnings	1,943	2,036	2,188	2,302	2,335	2,070	2,348	2,624	2,584	3,378
Other comprehensive income	-738	-666	-741	-817	-757	-359	-430	-366	-503	37.2
Shareholders' equity	1,532	1,707	1,759	1,803	1,900	1,837	2,066	2,424	2,272	3,614
Minority interests	22.3	23	13.2	13	10.9	12.1	6.98	7.5	14.6	18
Total equity	1,555	1,730	1,772	1,816	1,911	1,850	2,073	2,432	2,286	3,632
Total liabilities and equity	3,923	4,558	4,583	5,126	5,277	5,073	7,053	7,192	12,508	11,162
Shares outstanding	99.2	99.4	99.8	100	100	97.4	97.6	98	98.3	98.6

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	288	177	315	293	207	-82.7	467	476	164	1,003
Depreciation and amortization	205	218	236	239	261	245	309	341	375	519
Stock-based compensation	19.3	13.5	10.7	14.3	10.6	22.6	31.3	27.8	29.7	18
Deferred income tax	2.47	-19.8	-7.15	29.9	-5.21	-159	-10	-9.49	-57.1	15.6
Change in receivables	-44.7	-43.8	38.2	59.6	17.9	-150	-2.47	24.9	17.8	97.9
Change in inventory	-11.5	-16.1	-6.15	2.63	12.1	-130	-353	343	-13.3	-80.9
Cash from operations	399	348	590	426	706	299	509	883	834	690
Capital expenditures	-187	-189	-193	-196	-194	-256	-329	-363	-393	-344
Acquisitions	-88.6	-384	-277	-298	-49.3	-22.2	-1,427	-373	-3,794
Cash from investing	-3.14	-565	-444	-479	-126	-166	-1,741	-619	-4,106	2,196
Debt issued	241	449	227	277	1,122	172	2,153	963	4,061	66.7
Stock issued	0	0
Share buybacks	-107	-6.34	-14.6	-9.61	-8.48	-218	-4.55	-10.6	-9.25	-10.9
Dividends paid	-146	-153	-161	-170	-173	-179	-187	-197	-203	-208
Cash from financing	-316	203	-274	77.2	-163	-514	1,294	-352	3,668	-2,987
Exchange rate effect	-5.05	10.8	-6.64	0.94	3.15	-13.1	-5.35	12.9	-106	36.4
Net change in cash	74.8	-2.31	-135	24.9	420	-394	56.5	-75.5	291	-64.7
Free cash flow	212	159	397	230	511	42.7	180	520	441	346
Interest paid	53.4	57.2	63.1	66.8	71.7	68.2	88.2	136	151	261
Income taxes paid	135	97	103	82.5	65	134	123	190	92.4	265

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to March 29, 2026; growth uses fiscal years. Valuation uses the share price of $50.06 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	20.9%	Gross profit / revenue.
Operating margin	13.6%	Operating income / revenue.
EBITDA margin	20.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	10.3%	Pre-tax income / revenue.
Net margin	13.6%	Net income / revenue.
FCF margin	2.9%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	7.1%	Cash from operations / revenue.
Effective tax rate	22.2%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	28.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	9.2%	Net income / average total assets.
Return on invested capital (ROIC)	11.6%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	11.4%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.2%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	4.2%	Capital expenditures / revenue.
D&A / revenue	7.0%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	41.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	8.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	7.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	38.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	8.7%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	8.5%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	211.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	21.8%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	23.3%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	119.1%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	20.8%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	19.9%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	511.8%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	29.1%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	37.0%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	510.3%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	28.7%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	37.5%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-17.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	10.7%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-0.5%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-21.5%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	24.2%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-7.5%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	1.9%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	3.2%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	4.2%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	59.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	20.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	13.7%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-10.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	16.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	16.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.96x	Current assets / current liabilities.
Quick ratio	0.39x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.08x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.98x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	31.5%	Total debt / total assets.
Liabilities / assets	67.6%	Total liabilities / total assets.
Net debt	$3.26B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.12x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	4.59x	Operating income / interest expense.
Working capital	-$103.7M	Current assets - current liabilities.
Goodwill and intangibles / assets	45.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$1.51B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.68x	Revenue / average total assets.
Fixed asset turnover	2.73x	Revenue / average property, plant and equipment.
Inventory turnover	13.9x	Cost of revenue / average inventory.
Days inventory	26 days	365 x average inventory / cost of revenue.
Receivables turnover	8.38x	Revenue / average receivables.
Days sales outstanding	44 days	365 x average receivables / revenue.
Days payables	61 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	9 days	Days inventory + days sales outstanding - days payables.
FCF conversion	21.3%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	59.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$10.19	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$75.08	Revenue / diluted weighted shares.
FCF per share	$2.17	Free cash flow / diluted weighted shares.
Operating cash flow per share	$5.32	Cash from operations / diluted weighted shares.
Book value per share	$36.10	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$15.32	Tangible book value / shares outstanding.
Cash per share	$2.27	(Cash + short-term investments) / shares outstanding.
Payout ratio	20.6%	Dividends paid / net income, when net income is positive.
Dividends / FCF	96.6%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	3.4%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$4.95B	Share price x shares outstanding.
Enterprise value	$8.21B	Market cap + total debt - cash - short-term investments.
P/E	4.87x	Market cap / net income. Only when net income is positive.
P/S	0.66x	Market cap / revenue.
P/B	1.39x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	22.9x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	9.34x	Market cap / cash from operations, when positive.
EV/Sales	1.10x	Enterprise value / revenue.
EV/EBIT	8.07x	Enterprise value / operating income, when both are positive.
EV/EBITDA	5.33x	Enterprise value / EBITDA, when both are positive.
EV/FCF	37.9x	Enterprise value / free cash flow, when both are positive.
FCF yield	4.4%	Free cash flow / market cap.
Earnings yield	20.5%	Net income / market cap (the inverse of P/E).
Dividend yield	4.2%	Dividends paid over the period / market cap.
Shareholder yield	4.4%	(Dividends paid + share buybacks) / market cap.
PEG	0.17x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was SONOCO PRODUCTS CO's revenue in fiscal 2025?

SONOCO PRODUCTS CO reported revenue of $7.52B for fiscal 2025, 41.7% higher than the year before.

Was SONOCO PRODUCTS CO profitable in fiscal 2025?

Yes. Net income was $1.00B, a net margin of 13.3%.

How much free cash flow did SONOCO PRODUCTS CO generate in fiscal 2025?

Cash from operations of $689.8M minus capital expenditures of $344.0M left free cash flow of $345.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SONOCO PRODUCTS CO